Davide Santagata, Alessia Abenante, Alessandro Squizzato, Francesco Dentali, Marco Paolo Donadini, Walter Ageno, Ingrid Pabinger, Andreas Tiede, Cihan Ay
BACKGROUND: Venous thromboembolism (VTE) is a well-recognized complication after total joint replacement (TJR). Persons with hemophilia A or B are considered at low postoperative VTE risk due to their coagulation factor deficiencies, and administering pharmacologic thromboprophylaxis is often considered contraindicated. However, using factor replacement therapy could increase the postoperative VTE risk. OBJECTIVES: To analyze best available evidences of VTE rates in persons with hemophilia A or B undergoing lower limb TJR and the use of postoperative pharmacologic thromboprophylaxis...
January 11, 2024: Journal of Thrombosis and Haemostasis: JTH